Skip to content

The effect of fortified- bread with pomegranate peel powder in the treatment of diabetes

The effects of fortified-bread with pomegranate peel powder on anthropometric indices, lipid profile, glycemic indices, oxidative stress markers, mood and inflammation level in patients with type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191209045672N1
Enrollment
90
Registered
2020-09-21
Start date
2020-10-01
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus. Diabetes mellitus type 2 due to underlying condition

Interventions

Intervention 1: Intervention group: In this group, subjects will use 100 grams of enriched-bread with pomegranate peel powder daily for breakfast and snacks for 12 weeks. Intervention 2: Control group

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age 40-60 Body mass index less than 30 Glycosylated hemoglobin less than 8 Willing to participate in the study, diagnosis of diabetes in the last 5 years Understanding the objectives of the study Written consent

Exclusion criteria

Exclusion criteria: No complications of diabetes Using insulin or oral agents inducing insulin secretion Smoking Pregnancy Lactation Taking antioxidant supplements within the last 3 months Having a history of cancer, cardiovascular disease, renal, hepatic and thyroid disorders before the intervention

Design outcomes

Primary

MeasureTime frame
?Effect of fortified-bread with pomegranate peel powder on FBS level. Timepoint: Before intervention and after 12 weeks consumption of fortified-bread with pomegranate peel powder. Method of measurement: Measurement by laboratory kit.;?Effect of fortified-bread with pomegranate peel powder on HbA1c level. Timepoint: Before intervention and after 12 weeks consumption of fortified-bread with pomegranate peel powder. Method of measurement: Measurement by chromatography.;?Effect of fortified-bread with pomegranate peel powder on insulin level. Timepoint: Before intervention and after 12 weeks consumption of fortified-bread with pomegranate peel powder. Method of measurement: Measurement by laboratory kit.;?Effect of fortified-bread with pomegranate peel powder on lipid profile level. Timepoint: Before intervention and after 12 weeks consumption of fortified-bread with pomegranate peel powder. Method of measurement: Measurement by laboratory kit.;?Effect of fortified-bread with pomegranate peel powder on Malon dealdehyde level. Timepoint: Before intervention and after 12 weeks consumption of fortified-bread with pomegranate peel powder. Method of measurement: Measurement by laboratory kit.;?Effect of fortified-bread with pomegranate peel powder on total antioxidant capacity level. Timepoint: Before intervention and after 12 weeks consumption of fortified-bread with pomegranate peel powder. Method of measurement: Measurement by laboratory kit.;C-reactive protein measurement with high sensitivity. Timepoint: Before intervention and after 12 weeks consumption of fortified-bread with pomegranate peel powder. Method of measurement: Measurement by laboratory kit.

Secondary

MeasureTime frame
Depression, anxiety and stress scales. Timepoint: Before intervention and after 12 weeks consumption of fortified bread with pomegranate peel powder. Method of measurement: Questionnaire.;Weight. Timepoint: Before intervention and after 12 weeks consumption of fortified bread with pomegranate peel powder. Method of measurement: scales.;Waist. Timepoint: Before intervention and after 12 weeks consumption of fortified bread with pomegranate peel powder. Method of measurement: Measuring meter.;Blood pressure. Timepoint: Before intervention and after 12 weeks consumption of fortified bread with pomegranate peel powder. Method of measurement: Blood pressure measuring device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Amani

Esfahan University of Medical Sciences

r_amani@nutr.mui.ac.ir+98 31 3668 0048

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 10, 2026